Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Genentech, Inc. (NY: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Press releases about Genentech, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9 Next >
Zacks Analyst Interview Highlights: Genentech, Amgen and Biogen
February 26, 2008
from Business Wire News Releases
Genentech Receives Notification of Rejection of Cabilly Patent Claims From Reexamination Process
February 25, 2008
from Business Wire News Releases
BellwetherReport.com NYSE Analyst Review for MOT, LOW, DNA and FRE
February 25, 2008
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by The Bellwether Report. Read More
from Marketwired News Releases
Seven Summits Research Releases Comments on BAC, DNA, JNPR, ECA, and ZLC
February 25, 2008
from PR Newswire
FDA Grants Accelerated Approval of Avastin in Combination With Paclitaxel Chemotherapy for First-Line Treatment of Advanced HER2-Negative Breast Cancer
February 22, 2008
from Business Wire News Releases
SectorWatch.biz Issues MarketStats on CVBT, BSX, MDT, CXM and DNA
February 14, 2008
from PR Newswire
Seven Summits Research Releases Comments on AAPL, UNH, DNA, DF, and SWIM
February 13, 2008
from PR Newswire
AVADO Study of Avastin Plus Docetaxel Chemotherapy Showed Improved Progression-Free Survival in Patients with Advanced Breast Cancer
February 12, 2008
Results of Second Phase III Trial Support Potential of Avastin in Breast Cancer Read More
from Business Wire News Releases
Featured Stocks on Today's Edition of The Analyst's Review: DNA, CELG, GILD, ALNY, REGN
February 12, 2008
An all-new interview with Scott Sand, CEO of Ingen Technologies, Inc. is also available on WallSt.net Read More
from PR Newswire
Genentech and Biogen Idec Announce Positive Results from a Phase III Trial of Rituxan in Patients with Rheumatoid Arthritis Who Inadequately Responded to Methotrexate
January 25, 2008
First Phase III Study That Showed Symptom Improvement of Rituxan Plus Methotrexate in Biologic-Naive RA Patients Read More
from Business Wire News Releases
Featured Stocks on Today's Edition of The Analyst's Review: DNA, AMGN, BIIB, CELG, MLNM, BMRN
January 18, 2008
from PR Newswire
IRGR 2008 - Voting Period Ends Today
January 16, 2008
from PR Newswire
The Voting Period for the IRGR 2008 is Extended until January 16
January 15, 2008
from PR Newswire
Genentech Announces Full Year and Fourth Quarter 2007 Results
January 14, 2008
from Business Wire News Releases
Seven Summits Research Releases Comments on INTC, BK, USB, DNA and STT
January 14, 2008
from PR Newswire
Stocks in Focus on Today's Edition of 'Before the Bell:' WAG, CVS, GILD, DNA, GSK
January 04, 2008
from PR Newswire
Invitation to Investors and Analysts to Vote for the Companies with the Best IR Practices
January 03, 2008
from PR Newswire
Genentech Announces January 14 Webcast Discussion of Financial and Other Business Results
December 20, 2007
from Business Wire News Releases
Stocks in Focus on Today's Edition of 'Before the Bell:' NTDOY, SNE, MSFT, DNA, AMGN
December 17, 2007
from PR Newswire
Genentech Provides Update from Avastin FDA Advisory Meeting
December 05, 2007
from Business Wire News Releases
Registration for the 2008 IR Global Rankings Ends Today - 11:59 pm US ET
November 30, 2007
from PR Newswire
Final Reminder: Today is the Deadline to Register for the 2008 IR Global Rankings
November 30, 2007
More than 135 companies from 31 countries have already registered. We expect to have a record number of companies registered for the 2008 IRGR Read More
from PR Newswire
Last Day to Register for the 2008 IR Global Rankings: Deadline is November 30, 2007
November 29, 2007
More than 100 companies from 26 countries have already registered Read More
from PR Newswire
Avastin Shows Encouraging Results in Phase II Study in Patients With the Most Aggressive Form of Brain Cancer
November 18, 2007
from Business Wire News Releases
AOI Appoints CFO
November 16, 2007
from Business Wire News Releases
Seven Summits Research Releases Comments on HAL, LEH, DNA, GG, and SCHW
November 14, 2007
from PR Newswire
Genentech Oceanside (NIMO) Plant Hits Jackpot With ISPE 2007 Facility of the Year Award in Las Vegas, an Industrial Info News Alert
November 08, 2007
from Marketwired News Releases
Seven Summits Research Releases Alerts on IBM, NOK, DNA, TASR, and TAP
October 25, 2007
from PR Newswire
Genentech Announces Third Quarter 2007 Results
October 15, 2007
Genentech's Completion of Tanox Acquisition Reflected in Q3 Results Read More
from Business Wire News Releases
Genentech Announces October 15 Webcast Discussion of Earnings and Other Business Results
September 24, 2007
from Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here